Targeting dyslipidaemia to prevent cardiovascular disease

Dyslipidaemia is a key risk factor for cardiovascular disease, and its identification and treatment is important for both primary and secondary prevention. This article discusses how to screen for dyslipidaemia and optimise lipid‐lowering therapy to improve cardiovascular outcomes.

Saved in:
Bibliographic Details
Published inPrescriber (London, England) Vol. 30; no. 7; pp. 23 - 26
Main Authors Viljoen, Adie, Fuat, Ahmet, Takhar, Amrit, Williams, Simon, Capps, Nigel
Format Journal Article
LanguageEnglish
Published New York John Wiley & Sons, Inc 01.07.2019
Wiley Subscription Services, Inc
Subjects
Cardiovascular disease
Disease prevention
Drug therapy
Health risk assessment
Lipids
Metabolic disorders
Online AccessGet full text

Cover

More Information
Summary:Dyslipidaemia is a key risk factor for cardiovascular disease, and its identification and treatment is important for both primary and secondary prevention. This article discusses how to screen for dyslipidaemia and optimise lipid‐lowering therapy to improve cardiovascular outcomes.
ISSN:0959-6682
1931-2253
DOI:10.1002/psb.1775